Teva Pharmaceutical Industries Ltd.

Neurodegenerative Conditions and Movement Disorders

Neurodegenerative Conditions and Movement Disorders

There can be many challenges - physically, financially, and emotionally - faced every day by people living with diseases of the central nervous system and their families. Neurodegenerative conditions and movement disorders such as multiple sclerosis (MS), Parkinson’s Disease (PD), Huntington’s Disease (HD) and Tardive Dyskinesia (TD) affect every aspect of life, with even the most mundane tasks requiring great courage and effort. It is expected that by 2030, we will see a rise of between 30-50% in the incidence of such diseases, with an associated need for increased treatment and care. Teva provides a number of products to treat patients with neurological and neurodegenerative disorders – with a focus on helping patients manage their condition.